Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News
Gilead Breaks Ground on $32 Billion U.S. Innovation Commitment with New Technical Development Center in Foster City

Gilead Sciences celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the co...

September 04, 2025 | Thursday | News
Amgen to Invest $600 Million in New Science and Innovation Center at U.S. Headquarters

Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs   Amgen  announced plans to invest more than ...

September 04, 2025 | Thursday | News
How Does A PCR Technique Detect The Monkeypox Virus?

  According to recent statistics, the WHO (World Health Organization) has conducted an assessment of mpox cases in Africa, which showed that, as of 2...

September 03, 2025 | Wednesday | News
New Jersey: A Leading Life Sciences Manufacturing Hub

New Jersey at a Glance – Often dubbed the “Medicine Chest of the World,” New Jersey has a rich legacy and a dynamic present as a global h...

September 03, 2025 | Wednesday | Reports
Ryvu Partners with BioNTech to Accelerate Oncology Clinical Trial Access in Poland

Ryvu to support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clin...

September 03, 2025 | Wednesday | News
Novartis Leqvio Achieves Landmark Results in V-DIFFERENCE Phase IV Study

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LD...

September 02, 2025 | Tuesday | News
Roche and Alnylam Target Uncontrolled Hypertension with ZENITH Phase III Trial

Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 In the Phase II KA...

September 02, 2025 | Tuesday | News
Sectra and UMG Göttingen Pioneer AI Integration in German University Healthcare

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Universitätsmedizin Göttingen (UMG Göttinge...

September 02, 2025 | Tuesday | News
Foresight Diagnostics Reaches Licensing Agreement with Roche on PhasED-Seq™, Resolving Litigation

Foresight Diagnostics ("Foresight") announced that it has entered into a limited licensing agreement with Roche Molecular Systems and Roche Sequencing Sy...

September 01, 2025 | Monday | News
Piramal Pharma Solutions and George Medicines Achieve FDA Approval for WIDAPLIK, the First Triple Combination Hypertension Therapy

Piramal Pharma Solutions extended its robust CDMO capabilities to George Medicines to develop WIDAPLIK. WIDAPLIK is the first and only FDA-approved tr...

August 29, 2025 | Friday | News
Imbed Biosciences Launches SAM™ PainGuard™ with Lidocaine for Surgical, Burn, and Trauma Wound Care

 Imbed Biosciences Inc., a leader in advanced wound care technology,  announced the launch of SAM™ PainGuard™ with Lidocaine, ...

August 29, 2025 | Friday | News
CDT Equity Unveils New Target and Indication for AZD1656 via AI-Driven Drug Repurposing Strategy

CDT Equity Inc.  announces that it has successfully identified a new biological target and novel therapeutic indication for its lead programme, AZD1...

August 27, 2025 | Wednesday | News
Evoke Pharma Expands GIMOTI® Access Through Omnicell and Specialty Pharmacy Partnerships

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on developing treatments for gastrointestinal (GI) diseases, with a pa...

August 27, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close